4ZSC
Human Cyclophilin D Complexed with an Inhibitor at room temperature
4ZSC の概要
エントリーDOI | 10.2210/pdb4zsc/pdb |
関連するPDBエントリー | 3RDC |
分子名称 | Peptidyl-prolyl cis-trans isomerase F, mitochondrial, ethyl N-[(4-aminobenzyl)carbamoyl]glycinate (3 entities in total) |
機能のキーワード | isomerase inhibitor complex, isomerase |
由来する生物種 | Homo sapiens (Human) |
細胞内の位置 | Mitochondrion matrix : P30405 |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 17903.41 |
構造登録者 | Gelin, M.,Delfosse, V.,Allemand, F.,Hoh, F.,Sallaz-Damaz, Y.,Pirocchi, M.,Bourguet, W.,Ferrer, J.-L.,Labesse, G.,Guichou, J.-F. (登録日: 2015-05-13, 公開日: 2015-08-12, 最終更新日: 2024-05-08) |
主引用文献 | Gelin, M.,Delfosse, V.,Allemand, F.,Hoh, F.,Sallaz-Damaz, Y.,Pirocchi, M.,Bourguet, W.,Ferrer, J.L.,Labesse, G.,Guichou, J.F. Combining `dry' co-crystallization and in situ diffraction to facilitate ligand screening by X-ray crystallography. Acta Crystallogr.,Sect.D, 71:1777-1787, 2015 Cited by PubMed Abstract: X-ray crystallography is an established technique for ligand screening in fragment-based drug-design projects, but the required manual handling steps - soaking crystals with ligand and the subsequent harvesting - are tedious and limit the throughput of the process. Here, an alternative approach is reported: crystallization plates are pre-coated with potential binders prior to protein crystallization and X-ray diffraction is performed directly 'in situ' (or in-plate). Its performance is demonstrated on distinct and relevant therapeutic targets currently being studied for ligand screening by X-ray crystallography using either a bending-magnet beamline or a rotating-anode generator. The possibility of using DMSO stock solutions of the ligands to be coated opens up a route to screening most chemical libraries. PubMed: 26249358DOI: 10.1107/S1399004715010342 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.5 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード
